Why focus on uric acid?

Area of Science:

• Nephrology
• Cardiology
• Metabolic Diseases

Background:

• Gout management involves lowering serum uric acid (SUA) to below 6.0 mg/dL to dissolve urate deposits.
• Hyperuricemia frequently coexists with cardiovascular (CV) risk factors like hypertension, obesity, insulin resistance, fatty liver, and chronic kidney disease (CKD).
• Elevated SUA often precedes hypertension and metabolic syndrome, indicating a potential causal role.

Purpose of the Study:

• To review evidence on the role of serum uric acid in cardiovascular and renal disease.
• To explore the molecular mechanisms linking elevated SUA to these conditions.

Main Methods:

• Literature review based on PubMed/Embase database searches.
• Focus on articles concerning hyperuricemia and its impact on cardiovascular and renal function.

Main Results:

• Evidence suggests elevated SUA is a key factor in the development of CV and renal diseases.
• Molecular mechanisms underlying the causative association between SUA and these conditions are discussed.

Conclusions:

• Serum uric acid plays a significant role in the pathogenesis of cardiovascular and renal diseases.
• Understanding these mechanisms is crucial for managing hyperuricemia and associated comorbidities.